The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Helicobacter Pylori Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
The global Helicobacter Pylori Diagnostics market size is expected to reach US$ 1050.8 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Helicobacter Pylori Diagnostics in various end use industries. The expanding demands from the Hospitals and Clinics, Diagnostic Laboratories and Others,, are propelling Helicobacter Pylori Diagnostics market. Invasive Techniques, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-invasive Techniques segment is estimated at % CAGR for the next seven-year period.
Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Helicobacter Pylori Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Helicobacter Pylori Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Helicobacter Pylori Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Helicobacter Pylori Diagnostics covered in this report include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc.
The global Helicobacter Pylori Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Global Helicobacter Pylori Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Helicobacter Pylori Diagnostics market, Segment by Type:
Invasive Techniques
Non-invasive Techniques
Global Helicobacter Pylori Diagnostics market, by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Helicobacter Pylori Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
The global Helicobacter Pylori Diagnostics market size is expected to reach US$ 1050.8 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Helicobacter Pylori Diagnostics in various end use industries. The expanding demands from the Hospitals and Clinics, Diagnostic Laboratories and Others,, are propelling Helicobacter Pylori Diagnostics market. Invasive Techniques, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-invasive Techniques segment is estimated at % CAGR for the next seven-year period.
Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Helicobacter Pylori Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Helicobacter Pylori Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Helicobacter Pylori Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Helicobacter Pylori Diagnostics covered in this report include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc.
The global Helicobacter Pylori Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Global Helicobacter Pylori Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Helicobacter Pylori Diagnostics market, Segment by Type:
Invasive Techniques
Non-invasive Techniques
Global Helicobacter Pylori Diagnostics market, by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Helicobacter Pylori Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Helicobacter Pylori Diagnostics
1.1 Helicobacter Pylori Diagnostics Market Overview
1.1.1 Helicobacter Pylori Diagnostics Product Scope
1.1.2 Helicobacter Pylori Diagnostics Market Status and Outlook
1.2 Global Helicobacter Pylori Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Helicobacter Pylori Diagnostics Market Size by Region (2018-2029)
1.4 Global Helicobacter Pylori Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Helicobacter Pylori Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Helicobacter Pylori Diagnostics Market Size (2018-2029)
1.6.1 North America Helicobacter Pylori Diagnostics Market Size (2018-2029)
1.6.2 Europe Helicobacter Pylori Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Helicobacter Pylori Diagnostics Market Size (2018-2029)
1.6.4 Latin America Helicobacter Pylori Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Helicobacter Pylori Diagnostics Market Size (2018-2029)
2 Helicobacter Pylori Diagnostics Market by Type
2.1 Introduction
2.1.1 Invasive Techniques
2.1.2 Non-invasive Techniques
2.2 Global Helicobacter Pylori Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Helicobacter Pylori Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Helicobacter Pylori Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Helicobacter Pylori Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Helicobacter Pylori Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Helicobacter Pylori Diagnostics Revenue Breakdown by Type (2018-2029)
3 Helicobacter Pylori Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Diagnostic Laboratories
3.1.3 Others
3.2 Global Helicobacter Pylori Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Helicobacter Pylori Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Helicobacter Pylori Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Helicobacter Pylori Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Helicobacter Pylori Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Helicobacter Pylori Diagnostics Revenue Breakdown by Application (2018-2029)
4 Helicobacter Pylori Diagnostics Competition Analysis by Players
4.1 Global Helicobacter Pylori Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Helicobacter Pylori Diagnostics as of 2022)
4.3 Date of Key Players Enter into Helicobacter Pylori Diagnostics Market
4.4 Global Top Players Helicobacter Pylori Diagnostics Headquarters and Area Served
4.5 Key Players Helicobacter Pylori Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Helicobacter Pylori Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sekisui Diagnostics
5.1.1 Sekisui Diagnostics Profile
5.1.2 Sekisui Diagnostics Main Business
5.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Products, Services and Solutions
5.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Sekisui Diagnostics Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Medline Industries
5.3.1 Medline Industries Profile
5.3.2 Medline Industries Main Business
5.3.3 Medline Industries Helicobacter Pylori Diagnostics Products, Services and Solutions
5.3.4 Medline Industries Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Meridian Bioscience Recent Developments
5.4 Meridian Bioscience
5.4.1 Meridian Bioscience Profile
5.4.2 Meridian Bioscience Main Business
5.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Products, Services and Solutions
5.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Meridian Bioscience Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Products, Services and Solutions
5.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Alpha Laboratories
5.7.1 Alpha Laboratories Profile
5.7.2 Alpha Laboratories Main Business
5.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Products, Services and Solutions
5.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Alpha Laboratories Recent Developments
5.8 EKF Diagnostics
5.8.1 EKF Diagnostics Profile
5.8.2 EKF Diagnostics Main Business
5.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Products, Services and Solutions
5.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 EKF Diagnostics Recent Developments
5.9 Quidel
5.9.1 Quidel Profile
5.9.2 Quidel Main Business
5.9.3 Quidel Helicobacter Pylori Diagnostics Products, Services and Solutions
5.9.4 Quidel Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Quidel Recent Developments
5.10 Halyard Health
5.10.1 Halyard Health Profile
5.10.2 Halyard Health Main Business
5.10.3 Halyard Health Helicobacter Pylori Diagnostics Products, Services and Solutions
5.10.4 Halyard Health Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Halyard Health Recent Developments
5.11 Cardinal Health
5.11.1 Cardinal Health Profile
5.11.2 Cardinal Health Main Business
5.11.3 Cardinal Health Helicobacter Pylori Diagnostics Products, Services and Solutions
5.11.4 Cardinal Health Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Cardinal Health Recent Developments
5.12 Beckman Coulter
5.12.1 Beckman Coulter Profile
5.12.2 Beckman Coulter Main Business
5.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Products, Services and Solutions
5.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Beckman Coulter Recent Developments
5.13 Agilent Technologies
5.13.1 Agilent Technologies Profile
5.13.2 Agilent Technologies Main Business
5.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Products, Services and Solutions
5.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Agilent Technologies Recent Developments
5.14 Coris BioConcept
5.14.1 Coris BioConcept Profile
5.14.2 Coris BioConcept Main Business
5.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Products, Services and Solutions
5.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Coris BioConcept Recent Developments
6 North America
6.1 North America Helicobacter Pylori Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Helicobacter Pylori Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Helicobacter Pylori Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Helicobacter Pylori Diagnostics Market Dynamics
11.1 Helicobacter Pylori Diagnostics Industry Trends
11.2 Helicobacter Pylori Diagnostics Market Drivers
11.3 Helicobacter Pylori Diagnostics Market Challenges
11.4 Helicobacter Pylori Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
